BPR0C305, an orally active microtubule-disrupting anticancer agent
暂无分享,去创建一个
Chi-Hung Lin | C. Chen | Y. Chao | Jen‐Shin Song | T. Yeh | Wen-Tai Li | Y. Yang | Chien-Chang Shen | Chien‐Chang Shen | Heng‐Liang Lin | Tung‐Wei Chen | Ching‐Ping Chen | Chih-chien Hsieh
[1] M. Fujimuro,et al. Hyrtioreticulins A-E, indole alkaloids inhibiting the ubiquitin-activating enzyme, from the marine sponge Hyrtios reticulatus. , 2012, Bioorganic & medicinal chemistry.
[2] Yusuke Takahashi,et al. One-pot synthesis of 2-aminoquinoline-based alkaloids from acetonitrile. , 2012, Organic & biomolecular chemistry.
[3] L. Dubost,et al. Indole alkaloids from Muntafara sessilifolia with antiplasmodial and cytotoxic activities. , 2012, Phytochemistry.
[4] M. Iida,et al. Discovery of indole alkaloids with cannabinoid CB1 receptor antagonistic activity. , 2011, Bioorganic & medicinal chemistry letters.
[5] A. Magill,et al. Antimalarial activity of novel 5-aryl-8-aminoquinoline derivatives. , 2011, Journal of medicinal chemistry.
[6] Chi-Hung Lin,et al. BPR0C261 is a novel orally active antitumor agent with antimitotic and anti‐angiogenic activities , 2011, Cancer science.
[7] B. Tekwani,et al. Synthesis, antiprotozoal, antimicrobial, β-hematin inhibition, cytotoxicity and methemoglobin (MetHb) formation activities of bis(8-aminoquinolines). , 2011, Bioorganic & medicinal chemistry.
[8] Maria-José U. Ferreira,et al. Induction of apoptosis in HuH-7 cancer cells by monoterpene and beta-carboline indole alkaloids isolated from the leaves of Tabernaemontana elegans. , 2009, Bioorganic & medicinal chemistry letters.
[9] P. Roepe,et al. Overcoming drug resistance to heme-targeted antimalarials by systematic side chain variation of 7-chloro-4-aminoquinolines. , 2008, Journal of medicinal chemistry.
[10] R. Carlson. New tubulin targeting agents currently in clinical development. , 2008, Expert opinion on investigational drugs.
[11] L. Angenot,et al. Potential antimalarial activity of indole alkaloids. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[12] M. Hayashi,et al. Biologically active indole alkaloids from Kopsia arborea. , 2007, Journal of natural products.
[13] Vijayasaradhi Setaluri,et al. Microtubule-Associated Proteins as Targets in Cancer Chemotherapy , 2007, Clinical Cancer Research.
[14] M. Tsuda,et al. Hyrtinadine A, a bis-indole alkaloid from a marine sponge. , 2007, Journal of natural products.
[15] H. Hsieh,et al. Development and validation of a liquid chromatography-tandem mass spectrometry for the determination of BPR0L075, a novel antimicrotuble agent, in rat plasma: application to a pharmacokinetic study. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[16] M. Tsou,et al. Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas. , 2007, Journal of biomedical science.
[17] C. Chen,et al. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes. , 2006, Life sciences.
[18] G. Giannini,et al. Novel combretastatin analogues endowed with antitumor activity. , 2006, Journal of medicinal chemistry.
[19] J. Berlin,et al. The Pharmacokinetics and Safety of ABT-751, a Novel, Orally Bioavailable Sulfonamide Antimitotic Agent: Results of a Phase 1 Study , 2006, Clinical Cancer Research.
[20] Giovanni Sorba,et al. Medicinal chemistry of combretastatin A4: present and future directions. , 2006, Journal of medicinal chemistry.
[21] H. Takayama,et al. Isolation of gelsedine-type indole alkaloids from Gelsemium elegans and evaluation of the cytotoxic activity of gelsemium alkaloids for A431 epidermoid carcinoma cells. , 2006, Journal of natural products.
[22] Ji-Yun Kim,et al. Antimicrobial activity and cytotoxicity of bis(indole) alkaloids from the sponge Spongosorites sp. , 2006, Biological & pharmaceutical bulletin.
[23] T. Owa,et al. Sulfonamide drugs binding to the colchicine site of tubulin: thermodynamic analysis of the drug-tubulin interactions by isothermal titration calorimetry. , 2005, Journal of medicinal chemistry.
[24] Paraskevi Giannakakou,et al. Targeting microtubules for cancer chemotherapy. , 2005, Current medicinal chemistry. Anti-cancer agents.
[25] H. Gourdeau,et al. Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4H-chromenes, a novel series of anticancer agents. , 2004, Molecular cancer therapeutics.
[26] M. Hayashi,et al. Cytotoxic effects and reversal of multidrug resistance by ibogan and related indole alkaloids. , 2004, Bioorganic & medicinal chemistry letters.
[27] H. Hsieh,et al. BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity in Vivo , 2004, Cancer Research.
[28] F. Mollinedo,et al. Microtubules, microtubule-interfering agents and apoptosis , 2003, Apoptosis.
[29] Chi-Hung Lin,et al. Synthesis and biological evaluation of N-heterocyclic indolyl glyoxylamides as orally active anticancer agents. , 2003, Journal of medicinal chemistry.
[30] Kai Chen,et al. Structure-based 3-D-QSAR analysis of marine indole alkaloids. , 2002, Bioorganic & medicinal chemistry.
[31] R. Dorr,et al. Aziridinyl quinone antitumor agents based on indoles and cyclopent[b]indoles: structure-activity relationships for cytotoxicity and antitumor activity. , 2001, Journal of medicinal chemistry.
[32] S Seeber,et al. D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity. , 2001, Cancer research.
[33] G. Bifulco,et al. New bisindole alkaloids of the topsentin and hamacanthin classes from the Mediterranean marine sponge Rhaphisia lacazei. , 2000, Journal of natural products.
[34] T. Egan,et al. Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of beta-hematin formation, and antiplasmodial activity. , 2000, Journal of medicinal chemistry.
[35] I. Schlichting,et al. Crystal structure of wild-type tryptophan synthase complexed with the natural substrate indole-3-glycerol phosphate. , 1999, Biochemistry.
[36] P. Carlier,et al. Dual-site binding of bivalent 4-aminopyridine- and 4-aminoquinoline-based AChE inhibitors: contribution of the hydrophobic alkylene tether to monomer and dimer affinities. , 1999, Bioorganic & medicinal chemistry.
[37] G. McGaughey,et al. New generation dopaminergic agents. 6. Structure-activity relationship studies of a series of 4-(aminoethoxy)indole and 4-(aminoethoxy)indolone derivatives based on the newly discovered 3-hydroxyphenoxyethylamine D2 template. , 1999, Journal of medicinal chemistry.
[38] J. Schmidt,et al. New N-(pyridin-4-yl)-(indol-3-yl)acetamides and propanamides as antiallergic agents. , 1999, Journal of medicinal chemistry.
[39] Moore,et al. Isolation of a nitrile-containing indole alkaloid from the terrestrial blue-green alga hapalosiphon delicatulus , 1998, Journal of natural products.
[40] E. Hong,et al. Behavioural actions of the serotonergic anxiolytic indorenate , 1990, Pharmacology Biochemistry and Behavior.
[41] A. Bignamini,et al. Double-blind clinical evaluation of a new anti-inflammatory drug, protacine, versus indomethacin. , 1979, Current medical research and opinion.
[42] T. Baum,et al. Central and peripheral contribution to the antihypertensive action of indoramin. , 1975, European journal of pharmacology.